In total, Pfizer sold 25.7 billion dollars worth of medicines, which is about 24.4 billion euros. That is an increase of 77 percent compared to last year when the delivery of corona vaccines had just started. The profit came in at 7.9 billion dollars (7.5 billion euros), 61 percent more than a year earlier.
–
According to CEO Albert Bourla, Pfizer is well on track to deliver at least 2 billion doses of the corona vaccine to poor and developing countries this year and next. The production of the corona medicine Paxlovid is also in line with the schedule. In total, Pfizer has signed contracts worth $32 billion for the corona vaccine this year and $22 billion for Paxlovid.
–
The demand for the vaccines will remain high in the coming period, Bourla believes. For example, vaccines are being made more widely available in some countries and new outbreaks are still occurring worldwide.
–
Pfizer has decided to remain active in the Russian market because the company focuses on promoting the health of people and therefore also Russians. Profits from the Russian market are donated to charities in Ukraine.
–
